SurGenTec’s ALARA™ Access Needle Awarded Best Spine Technology for 2018

BOCA RATON, Fla.--(BUSINESS WIRE)-- SurGenTec® LLC, a South Florida based medical device company has been awarded the 2018 Orthopedics This Week Spine Technology Award and will be formally receiving their award during the 2018 North American Spine Society meeting. This year’s meeting will be held Sept. 26^th -28^th in Los Angeles, CA. The awarded technology from SurGenTec’s product line is the unique and innovative ALARA ™ access needle. The access needle will be offered in multiple variations including with and without a depth stop. When combined with their patented fully adjustable extension handle the user can maintain superior target needle manipulation while also reducing radiation exposure. The extension handle allows users to maintain maximum source-to-skin distance between their hands and the primary x-ray beam without sacrificing precision and control. A white paper study revealed a reduction in radiation exposure of 293 times less than standard needle manipulation and 15 times less than using a Kocher Clamp. The ALARA access needle is set for release in Mid-October.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180925006141/en/

ALARA Access Needle (Photo: Business Wire)

Travis Greenhalgh, CEO of SurGenTec stated in a recent interview, “Although its often overlooked in the industry, many surgeons reach dangerous levels of radiation exposure annually and SurGenTec is on a mission to decrease those numbers and raise awareness.”

SurGenTec, LLC is a medical device company based in Boca Raton, FL that strives to bring the next level of technology to the spine and orthopedic industry. SurGenTec develops and manufactures innovative products with patient and surgeon safety at the heart of everything they develop. SurGenTec has already made their presence known with the GraftGun® Universal Graft Delivery System which launched earlier this year and are excited to add the awarded ALARA to their portfolio. SurGenTec will also be showcasing their pre-filled MIS cartridge options at NASS, including ViBone® viable bone matrix. SurGenTec partnered with Aziyo® Biologics to provide ViBone next generation bone graft in an MIS cartridge to reduce thawing time, cross contamination, and delivery issues. SurGenTec has multiple products in their pipeline set for release over the next year.

www.surgentec.com
7601 N Federal Hwy., Suite 150A
Boca Raton, FL 33487
561-990-7882 / customerservice@surgentec.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20180925006141/en/